Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xipayi Guyin Ye for prevention of radiation-induced oral mucositis in nasopharyngeal carcinoma (Phase II)
CTR20250038Phase 2Suspended
- Sponsor
- Xinqikang Pharmaceutical
- Start
- Mar 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Xipayi Guyin Ye in oral mucositis (OM), sponsored by Xinqikang Pharmaceutical. Started Mar 2025; status: suspended.
02
Drugs
Xipayi Guyin Ye
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on CTR20250038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250038.